Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-24 @ 11:16 PM
NCT ID:
NCT04021056
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of HCC;
* Age ≥ 16 years;
* Received treatment targeting for HCC at least once, including operation, ablation, TACE, sorafenib, radiotherapy, chemotherapy, etc;
* Good compliance with clinical treatment.
Exclusion Criteria:
* Diagnosed as other pathological types such as cholangiocarcinoma, or mixed liver cancer;
* Received only traditional Chinese medicine or symptomatic supportive treatment; (3) survival time ≤ 7 days;
* HCC diagnosed after liver transplantation;
* Poor compliance or important data deficient.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT04021056
Study Brief:
Protocol Section:
NCT04021056